The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility.

IF 3.9
Melissa Assel, Andrew Vickers
{"title":"The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility.","authors":"Melissa Assel, Andrew Vickers","doi":"10.1186/s41512-025-00214-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The F score is derived from precision (positive predictive value) and recall (sensitivity). It is increasingly used to evaluate diagnostic tests and prediction models in the machine learning literature. Although precision and recall can be differentially weighted using a parameter β, almost all applications use equal weighting, with β set to 1.</p><p><strong>Methods: </strong>We considered a cancer detection scenario to explore the properties of the F score in comparison to net benefit, a well-established method for evaluating the clinical utility of tests and models. Because missing cancer can be fatal and biopsies are an invasive procedure, we would favor a test with high sensitivity.</p><p><strong>Results: </strong>F scores did not provide a rank ordering of tests consistent with utility. F1 was highest for a test with greater specificity; in contrast, the conventional decision analytic measure, net benefit, rank ordered tests consistent with clinical intuition, with the highest sensitivity test favored. While it might be argued that F scores can be made consistent with utility by choosing a value of β different from 1, we found it is impossible to rationally prespecify β for any given clinical scenario, as even small changes in prevalence led to undesirable rank orderings for a given β being inconsistent with utility.</p><p><strong>Conclusion: </strong>The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility. Moreover, the F score does not have an interpretable unit, does not allow for a comparison with a strategy assuming all are negative, and requires dichotomization of models. In contrast, standard decision-analytic measures - net benefit and decision curve analysis - allow rational and consistent choice of weighting, have an interpretable unit, can evaluate the strategy of assuming all are negative, and do not require dichotomization of continuous models. Consistent with TRIPOD AI we recommend that net benefit, alongside discrimination and calibration, be used for the evaluation of diagnostic tests and prediction models.</p>","PeriodicalId":72800,"journal":{"name":"Diagnostic and prognostic research","volume":"9 1","pages":"30"},"PeriodicalIF":3.9000,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683848/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic and prognostic research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41512-025-00214-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The F score is derived from precision (positive predictive value) and recall (sensitivity). It is increasingly used to evaluate diagnostic tests and prediction models in the machine learning literature. Although precision and recall can be differentially weighted using a parameter β, almost all applications use equal weighting, with β set to 1.

Methods: We considered a cancer detection scenario to explore the properties of the F score in comparison to net benefit, a well-established method for evaluating the clinical utility of tests and models. Because missing cancer can be fatal and biopsies are an invasive procedure, we would favor a test with high sensitivity.

Results: F scores did not provide a rank ordering of tests consistent with utility. F1 was highest for a test with greater specificity; in contrast, the conventional decision analytic measure, net benefit, rank ordered tests consistent with clinical intuition, with the highest sensitivity test favored. While it might be argued that F scores can be made consistent with utility by choosing a value of β different from 1, we found it is impossible to rationally prespecify β for any given clinical scenario, as even small changes in prevalence led to undesirable rank orderings for a given β being inconsistent with utility.

Conclusion: The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility. Moreover, the F score does not have an interpretable unit, does not allow for a comparison with a strategy assuming all are negative, and requires dichotomization of models. In contrast, standard decision-analytic measures - net benefit and decision curve analysis - allow rational and consistent choice of weighting, have an interpretable unit, can evaluate the strategy of assuming all are negative, and do not require dichotomization of continuous models. Consistent with TRIPOD AI we recommend that net benefit, alongside discrimination and calibration, be used for the evaluation of diagnostic tests and prediction models.

Abstract Image

Abstract Image

Abstract Image

F分数对诊断测试和预测模型的排名与它们的临床效用不一致。
背景:F分来源于精密度(阳性预测值)和召回率(敏感性)。在机器学习文献中,它越来越多地用于评估诊断测试和预测模型。虽然精度和召回率可以使用参数β进行不同的加权,但几乎所有的应用程序都使用相同的加权,β设为1。方法:我们考虑了一个癌症检测场景,以探索F评分与净效益的特性,净效益是评估测试和模型临床效用的一种行之有效的方法。因为遗漏癌症可能是致命的,而活组织检查是一种侵入性的检查,我们倾向于高灵敏度的检查。结果:F分数没有提供与效用一致的测试排序。特异性较强的试验F1最高;相比之下,传统的决策分析措施,净效益,排序测试符合临床直觉,以最高的灵敏度测试青睐。虽然有人可能会认为,通过选择不同于1的β值,F分数可以与效用保持一致,但我们发现,对于任何给定的临床情况,都不可能合理地预先指定β,因为即使患病率的微小变化也会导致给定β与效用不一致的不良排序。结论:F评分对诊断测试和预测模型的排序与其临床应用不一致。此外,F分数没有可解释的单位,不允许与假设全部为负的策略进行比较,并且需要对模型进行二分类。相比之下,标准决策分析措施-净效益和决策曲线分析-允许合理和一致的权重选择,具有可解释的单位,可以评估假设全部为负的策略,并且不需要连续模型的二分类。与TRIPOD AI一致,我们建议将净效益与判别和校准一起用于诊断测试和预测模型的评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书